Last $1.85 USD
Change Today -0.0101 / -0.54%
Volume 19.2K
VRML On Other Exchanges
As of 1:25 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

vermillion inc (VRML) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/4/14 - $3.83
52 Week Low
12/9/14 - $1.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VERMILLION INC (VRML)

Related News

No related news articles were found.

vermillion inc (VRML) Related Businessweek News

No Related Businessweek News Found

vermillion inc (VRML) Details

Vermillion, Inc., together with its subsidiaries, is engaged in the discovery, development, and commercialization of diagnostic tests that help physicians diagnose, treat, and enhance outcomes for patients. It develops diagnostic tests in the fields of oncology and women’s health. The company’s lead product is OVA1, an ovarian cancer blood test for pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices. The company was founded in 1993 and is headquartered in Austin, Texas.

26 Employees
Last Reported Date: 03/31/14
Founded in 1993

vermillion inc (VRML) Top Compensated Officers

Principal Financial Officer, Chief Accounting...
Total Annual Compensation: $184.0K
Chief Scientific Officer, Senior Vice Preside...
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

vermillion inc (VRML) Key Developments

Vermillion, Inc. Announces Executive Appointments

Vermillion, Inc. announced that it has appointed Laura Miller to the newly created position of Senior Vice President of Sales/Customer Experience. Ms. Miller will report directly to Valerie Palmieri, President & Chief Executive Officer. Holly Bauzon, previously Vice President of Sales and Managed Markets, will now be solely dedicated to leading managed markets. This more focused position will better enable the company to build its managed care foundation. Laura has spent 17 years in the diagnostics industries, serving in numerous sales, operations and executive capacities for laboratory service and capital equipment organizations. Prior to serving as an independent healthcare consultant for the last four years, she served as President, Laboratory Services, for HealthTronics Laboratory, from 2008-2010. In addition, she served in several senior leadership roles at PLUS Diagnostics, DIANON Systems, U.S. Labs and Ventana Medical Systems.

Vermillion, Inc. Announces Executive Changes

Vermillion, Inc. announced the next step in its expanded strategy to rebuild the company into a premier bio-analytics solutions provider with the naming of current Chief Operating Officer, Valerie Palmieri to President and Chief Executive Officer, while current Chairman of the Board and CEO James LaFrance will continue to serve as Chairman. These changes are effective January 1, 2015. As Chairman of the Board, he will continue to actively work with her and the management team to achieve the vision have crafted together.

Vermillion, Inc. Announces Board Appointments

Vermillion, Inc. announced the appointments of Veronica G. H. Jordan, Ph.D., and David R. Schreiber to the company's board of directors, bringing the total number of directors to eight, seven of whom are independent. Veronica Jordan, Ph.D. is an accomplished entrepreneur and international business leader.  David Schreiber has more than 30 years of corporate and consulting experience in the healthcare industry, particularly in the area of corporate finance, operations, and mergers and acquisitions.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $1.85 USD -0.0101

VRML Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arrayit Corp $0.08 USD +0.0163
Health Discovery Corp $0.02 USD +0.0027
Imperial Innovations Group PLC 452.00 GBp +2.50
MDxHealth €4.96 EUR -0.12
Miraculins Inc C$0.17 CAD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation VRML Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 26.8x
Price/Book 5.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 25.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at